Computer Image Analysis Reveals C-Myc as a Potential Biomarker for Discriminating between Keratoacanthoma and Cutaneous Squamous Cell Carcinoma

Table 1

Summary of clinical characteristics of Keratoacanthoma (KA) and Cutaneous Squamous Cell Carcinoma (cSCC) patients.

	KA	cSCC	value
Patients	42	30
Age (years)			0.907
Gender (, %)			0.690
Female	19 (45.24%)	15 (50.0%)
Male	23 (54.80%)	15 (50.0%)
Site (, %)			0.000
Head and neck	35 (83.3%)	11 (36.7%)
Body	4 (9.5%)	11 (36.7%)
Arms and legs	39 (7.1%)	8 (26.7%)